1471 Protocol BFM-95 in Treatmant of Chilhood Acute Lymphoblastic Leukemia (All) and Lymphoblastic Lymphoma (Ll)

Archives of Disease in Childhood - United Kingdom
doi 10.1136/archdischild-2012-302724.1471
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

IKZF1 Deletion Is an Independent Predictor of Outcome in Pediatric Acute Lymphoblastic Leukemia Treated According to the ALL-BFM 2000 Protocol

Klinische Padiatrie
MedicineChild HealthPediatricsPerinatology
2011English

Prognostic Impact of IKZF1 Deletions in Association With Vincristine–dexamethasone Pulses During Maintenance Treatment of Childhood Acute Lymphoblastic Leukemia on Trial ALL-BFM 95

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2017English

Acute Lymphoblastic Leukemia

English

Acute Lymphoblastic Leukemia

2016English

Acute Lymphoblastic Leukemia

2020English

Epoetin Alpha Decreases the Number of Erythrocyte Transfusions in Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, and Burkitt Leukemia/Lymphoma

Cancer
Cancer ResearchOncology
2011English

Acute Lymphoblastic Leukemia

2009English

Acute Lymphoblastic Leukemia

2019English

Pediatric Acute Lymphoblastic Leukemia

Hematology & Transfusion International Journal
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy